Literature DB >> 8478967

Plasma glucose and insulin responses to oral glucose loading in nonobese Nigerian subjects with essential hypertension.

A O Akanji1, A C Ojule, S Kadiri, B O Osotimehin.   

Abstract

In assessing the relationship between insulin levels and blood pressure, we analyzed glucose and insulin data after standard 75 g oral glucose tolerance tests in 16 nonobese male Nigerian subjects with essential hypertension and compared their results with those obtained from 16 age- and sex-matched healthy normotensive subjects. The fasting plasma glucose and insulin as well as 2-hour postload insulin values were similar in both groups. The hypertensive subjects had significantly greater 2-hour glucose levels, larger incremental areas under the glucose/time curves, and smaller ratios of incremental insulin to incremental glucose areas (P < .05). These parameters suggest some impairment of glucose tolerance in the hypertensive subjects related to an inadequate insulin response to the oral glucose load. Model analysis of the glucose and insulin data confirmed these observations in that the estimated rate of glucose uptake into peripheral tissues (M value) was lower in the hypertensive subjects (P = .02). There was no correlation at any time point between insulin values and blood pressure in either group of subjects. These results suggest that essential hypertension in Nigerian diabetic subjects is associated with a reduced insulin response to glucose loading, which is at variance with reports in whites, and deserve further investigation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478967      PMCID: PMC2571903     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  23 in total

1.  Diabetes mellitus in Nigerians: a study of 832 patients.

Authors:  B O Osuntokun; F M Akinkugbe; T I Francis; S Reddy; O Osuntokun; G O Taylor
Journal:  West Afr Med J Niger Pract       Date:  1971-10

2.  Increased in vivo insulin resistance in nondiabetic Pima Indians compared with Caucasians.

Authors:  M Nagulesparan; P J Savage; W C Knowler; G C Johnson; P H Bennett
Journal:  Diabetes       Date:  1982-11       Impact factor: 9.461

3.  Insulin and blood pressure in obesity.

Authors:  C P Lucas; J A Estigarribia; L L Darga; G M Reaven
Journal:  Hypertension       Date:  1985 Sep-Oct       Impact factor: 10.190

4.  Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus.

Authors:  H S Seltzer; E W Allen; A L Herron; M T Brennan
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

5.  Nonketotic diabetes mellitus: insulin deficiency or insulin resistance?

Authors:  G M Reaven; R Bernstein; B Davis; J M Olefsky
Journal:  Am J Med       Date:  1976-01       Impact factor: 4.965

6.  Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp.

Authors:  M S Greenfield; L Doberne; F Kraemer; T Tobey; G Reaven
Journal:  Diabetes       Date:  1981-05       Impact factor: 9.461

7.  Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.

Authors:  T Shinozawa; M C Villadolid; S H Ingbar
Journal:  J Clin Endocrinol Metab       Date:  1986-01       Impact factor: 5.958

8.  Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.

Authors:  M Modan; H Halkin; S Almog; A Lusky; A Eshkol; M Shefi; A Shitrit; Z Fuchs
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

9.  Postprandial hyperinsulinemia in patients with mild essential hypertension.

Authors:  P Singer; W Gödicke; S Voigt; I Hajdu; M Weiss
Journal:  Hypertension       Date:  1985 Mar-Apr       Impact factor: 10.190

10.  Racial differences in the relation between blood pressure and insulin resistance.

Authors:  M F Saad; S Lillioja; B L Nyomba; C Castillo; R Ferraro; M De Gregorio; E Ravussin; W C Knowler; P H Bennett; B V Howard
Journal:  N Engl J Med       Date:  1991-03-14       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.